Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Synthon Biopharmaceuticals B.V.
*STREET
Microweg 22
*CITY
CM Nijmegen
*COUNTRY
Netherlands
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
6545
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED
Netherlands
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for the treatment of cancer
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
1394715
FOREIGN APPLICATION
COUNTRY
Benelux
FOREIGN FILING DATE
04/26/2019
INTENT TO
PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88471824
Filing Date:06/13/2019
To the Commissioner for Trademarks:
MARK: HERVISBA (Standard Characters, see mark)
The literal element of the mark consists of HERVISBA.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Synthon Biopharmaceuticals B.V., a limited liability company legally organized under the laws of Netherlands, having an address of
Microweg 22
CM Nijmegen 6545
Netherlands
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the treatment of cancer
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Benelux application number 1394715, filed 04/26/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
Benelux registration number 1394715, and/or proof of renewal, registered 05/06/2019 with a renewal date of __________ and an expiration date of 04/26/2029, and translation thereof, if
appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
The applicant's current Attorney Information:
E. Anthony Figg and Leo M. Loughlin, Davide F. Schiavetti of Rothwell, Figg, Ernst & Manbeck, pc
Suite 800
607 14th Street NW
Washington, District of Columbia 20005
United States
202-783-6040(phone)
202-783-6031(fax)
PTO-TM-Email@rfem.com (authorized)
The attorney docket/reference number is 3599-148.
The applicant hereby appoints E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, pc
Suite 800
607 14th Street NW
Washington District of Columbia 20005
United States
202-783-6040(phone)
202-783-6031(fax)
PTO-TM-Email@rfem.com (authorized)
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
E. Anthony Figg
Rothwell, Figg, Ernst & Manbeck, PC
Suite 800
607 14th Street NW
Washington, District of Columbia 20005
202-783-6040(phone)
202-783-6031(fax)
PTO-TM-Email@rfem.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Leo M. Loughlin/ Date: 06/13/2019
Signatory's Name: Leo M. Loughlin
Signatory's Position: Attorney of Record, D.C. Bar Member
Payment Sale Number: 88471824
Payment Accounting Date: 06/13/2019
Serial Number: 88471824
Internet Transmission Date: Thu Jun 13 13:10:07 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2019061313100772
6775-88471824-620fb836b3ddf6ae8ba06f2f71
418412795faafa2373cf902f4f3335c11da5fce-
DA-13812-20190613111703468893